AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

Epigenetic modulation of thyroid cancer metastasis and glycolysis through circSSU72-mediated ubiquitination of gamma-catenin and beta-catenin signaling

Zeyu Zhanga,bDuntao Sua,bXiangyuan Qiua,bLei Yaob,cFada Xiaa,b( )Xinying Lia,b
Department of Thyroid Surgery, Xiangya Hospital, Central South University, Changsha, Hunan 410000, China
National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan 410000, China
Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan 410000, China

Peer review under the responsibility of the Genes & Diseases Editorial Office, in alliance with the Association of Chinese Americans in Cancer Research (ACACR, Baltimore, MD, USA).

Show Author Information

References

【1】
【1】
 
 
Genes & Diseases
Article number: 101485

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Zhang Z, Su D, Qiu X, et al. Epigenetic modulation of thyroid cancer metastasis and glycolysis through circSSU72-mediated ubiquitination of gamma-catenin and beta-catenin signaling. Genes & Diseases, 2025, 12(4): 101485. https://doi.org/10.1016/j.gendis.2024.101485

246

Views

1

Downloads

1

Crossref

1

Web of Science

1

Scopus

0

CSCD

Received: 21 April 2024
Published: 07 December 2024
© 2024 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).